Trial Updates

Aug 28, 2025, 15:55

ANKTIVA NK Cell Therapy Shows 100 Percent Disease Control in Recurrent Glioblastoma – ImmunityBio

ImmunityBio shared a post on X:

”We’ve announced that our initial data shows 100% disease control in 5 out of 5 patients with recurrent glioblastoma after being treated with our ANKTIVA, NK cell therapy plus the Optune Gio device.”

Proceed to the video attached to the post.

More posts featuring ImmunityBio.

Anktiva cancer cancer treatment glioblastoma ImmunityBio OncoDaily Oncology Optune Gio

10 Leading Experts Join OncoDaily Journal Editorial Team

Top 10 Oncogrants of the Week: Fueling Cancer Research and Innovation

Soon-Shiong’s “Bioshield” Sparks Early Promise in Recurrent GBM, With 2 Near-CRs and 100% Disease Control

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

China Approved DATROWAY (Datopotamab Deruxtecan) for HR-Positive, HER2-Negative Metastatic Breast Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Trial Updates

Aug 28, 2025, 15:55

David Heredia: LEOPARD Study Highlights Early NSCLC Recurrence

Trial Updates

Aug 28, 2025, 15:55

ANKTIVA NK Cell Therapy Shows 100 Percent Disease Control in Recurrent Glioblastoma - ImmunityBio

Insight

Aug 28, 2025, 15:54

Bishal Gyawali: Inferior Control Arms in LMIC Oncology Trials in a New BMJ Oncology Editorial

Voices

Aug 28, 2025, 15:53

Talha Badar: TP53-Mutated MPN in British Journal of Haematology

Career Updates

Aug 28, 2025, 15:52

Hassan Abushukair: Celebrating My Term as Co-Chair of the AACR Global Scholars Alumni Committee

Voices

Aug 28, 2025, 15:48

ESO and OECI Invite Clinicians and Researchers to Contribute to the 10th CCI4EU Training Cours

Insight

Aug 28, 2025, 15:48

Mansi Shah Highlights Promising CNS Activity of Bispecific Antibodies

Voices

Aug 28, 2025, 15:40

What if You Could Lock Disease Biology Into Place? - Amgen

Voices

Aug 28, 2025, 15:28

Liver Cancer is Preventable? - CUHK Medicine

Science

Aug 28, 2025, 15:27

Jarushka Naidoo: A Novel Method to Detect Brain Tumours through CSF-BAM

Voices

Aug 28, 2025, 15:19

Hagop Youssoufian Highlights TREOS BIO's Collaboration in Colorectal Cancer Treatment

Insight

Aug 28, 2025, 15:15

Erika Hamilton Highlights MonarchE Trial Success in HR+ Breast Cancer